Agios Pharmaceuticals Inc (AGIO)
43.11
-0.50
(-1.15%)
USD |
NASDAQ |
Jun 28, 16:00
43.03
-0.08
(-0.19%)
After-Hours: 20:00
Agios Pharmaceuticals Accounts Receivable (Quarterly): 3.453M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.453M |
December 31, 2023 | 2.81M |
September 30, 2023 | 1.176M |
June 30, 2023 | 2.251M |
March 31, 2023 | 1.778M |
December 31, 2022 | 2.206M |
September 30, 2022 | 1.818M |
June 30, 2022 | 1.598M |
March 31, 2022 | 0.54M |
December 31, 2021 | 0.00 |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | 23.32M |
June 30, 2020 | 18.04M |
March 31, 2020 | 19.72M |
December 31, 2019 | 15.32M |
September 30, 2019 | 12.41M |
June 30, 2019 | 14.59M |
March 31, 2019 | 10.51M |
Date | Value |
---|---|
December 31, 2018 | 10.44M |
September 30, 2018 | 8.329M |
June 30, 2018 | 21.34M |
March 31, 2018 | 4.929M |
December 31, 2017 | 3.67M |
September 30, 2017 | 4.204M |
June 30, 2017 | 4.842M |
March 31, 2017 | 11.26M |
December 31, 2016 | 4.886M |
September 30, 2016 | 8.182M |
June 30, 2016 | 7.853M |
March 31, 2016 | 6.814M |
December 31, 2015 | 8.225M |
September 30, 2015 | 9.078M |
June 30, 2015 | 10.47M |
March 31, 2015 | 7.017M |
December 31, 2014 | 6.492M |
September 30, 2014 | 18.76M |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | 0.476M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
23.32M
Maximum
Sep 2020
7.096M
Average
2.251M
Median
Jun 2023
Accounts Receivable (Quarterly) Benchmarks
Arcutis Biotherapeutics Inc | 37.15M |
Insmed Inc | 37.16M |
Krystal Biotech Inc | 46.47M |
Arvinas Inc | -- |
BridgeBio Pharma Inc | -- |